Old Web
English
Sign In
Acemap
>
authorDetail
>
E. Vilar Gomez
E. Vilar Gomez
Diabetes mellitus
Medicine
Internal medicine
Virology
Gastroenterology
5
Papers
83
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
874 AMINOTRANSFERASE LEVELS ACCURATELY PREDICT NAFLD ACTIVITY SCORE AFTER 24 WEEKS OF INTERVENTION. RESULTS BASED ON MULTIPLE LINEAR REGRESSION MODEL
2011
Journal of Hepatology
E. Vilar Gomez
E Arus-soler
A. Yasells Garcia
M.D.R. Abreu Vazquez
Show All
Source
Cite
Save
Citations (0)
Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease
2009
Alimentary Pharmacology & Therapeutics
E. Vilar Gomez
A. Rodríguez de Miranda
B. Gra Oramas
E Arus-soler
R. Llanio Navarro
L. Calzadilla Bertot
A. Yasells Garcia
M. Del Rosario Abreu Vazquez
Show All
Source
Cite
Save
Citations (83)
314 VIUSID, A NUTRITIONAL SUPPLEMENT, IN PATIENTS WITH CHRONIC HEPATITIS C AND CIRRHOSIS. A RANDOMIZED AND CONTROLLED STUDY
2008
Journal of Hepatology
E. Vilar Gomez
Y. Sanchez Rodriguez
E Arus-soler
B. Gra Oramas
Show All
Source
Cite
Save
Citations (0)
979 VIUSID, A NUTRITIONAL SUPLEMENT, IN COMBINATION WITH DIET AND EXERCISE AS INITIAL STRATEGY OF TREATMENT IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS
2008
Journal of Hepatology
E. Vilar Gomez
A. Rodríguez de Miranda
B. Gra Oramas
E Arus-soler
Show All
Source
Cite
Save
Citations (0)
P.264 Viusid in combination with interferon alpha-2b and ribavirin in patients with chronic hepatitis C. Efficacy and safety results from a ramdomized controlled trial
2006
Journal of Clinical Virology
E. Vilar Gomez
B. Gra
E Arus-soler
C. Ruenes Domech
Y. Betancourt
Show All
Source
Cite
Save
Citations (0)
1